Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,199 | -20,339 | -9,045 | -65,952 | -26,985 |
| Depreciation Amortization | 614 | -49 | 347 | 32,268 | 1,202 |
| Other Working Capital | -3,912 | -5,101 | -5,765 | 539 | -906 |
| Other Operating Activity | 4,640 | 3,193 | 1,575 | 6,688 | 5,258 |
| Operating Cash Flow | $-28,857 | $-22,296 | $-12,888 | $-26,457 | $-21,431 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,186 | -12,186 | -12,186 | -43,550 | -14,428 |
| PPE Investments | -45 | -8 | -6 | -120 | -114 |
| Sale Of Investment | 50,820 | 44,405 | 22,052 | 58,620 | 47,837 |
| Investing Cash Flow | $38,589 | $32,211 | $9,860 | $14,950 | $33,295 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -91 | -64 | -64 | -90 | -90 |
| Financing Cash Flow | $-91 | $-64 | $-64 | $-90 | $-90 |
| Beginning Cash Position | 24,872 | 24,872 | 24,872 | 36,469 | 36,469 |
| End Cash Position | 34,513 | 34,723 | 21,780 | 24,872 | 48,243 |
| Net Cash Flow | $9,641 | $9,851 | $-3,092 | $-11,597 | $11,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,857 | -22,296 | -12,888 | -26,457 | -21,431 |
| Capital Expenditure | -45 | -8 | -6 | -120 | -114 |
| Free Cash Flow | -28,902 | -22,304 | -12,894 | -26,577 | -21,545 |